MAYZENT
LIVE

Serial Number

79261592

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

May 3, 2019

Add to watchlist:

No watchlists yet
View on USPTO

MAYZENT Trademark

Serial Number: 79261592 • Registration: 6010378

MAYZENT is a trademark filed by NOVARTIS AG on May 3, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,174 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

May 3, 2019

Registration Date

March 17, 2020

Published for Opposition

December 31, 2019

Goods & Services

[ Anti-infectives; ] anti-inflammatories; [ antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system; [ pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; ] pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, [ the endocrine system, ] the musculo-skeletal system [ and the genitourinary system ] ; [ pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; ] pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders [ ; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]

Filing History

NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
Feb 3, 2026 NA75
REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
Feb 3, 2026 C75A
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 26, 2026 APRE
TEAS SECTION 71 & 15 RECEIVED
Sep 16, 2025 ES75
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Mar 17, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Aug 7, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Jul 23, 2020 FICS
FINAL DISPOSITION PROCESSED
Jul 23, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jun 17, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Mar 17, 2020 R.PR
NOTIFICATION PROCESSED BY IB
Jan 4, 2020 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 31, 2019 NPUB
PUBLISHED FOR OPPOSITION
Dec 31, 2019 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Dec 18, 2019 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Dec 18, 2019 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 11, 2019 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 23, 2019 CNSA
REFUSAL PROCESSED BY IB
Sep 6, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 19, 2019 RFCS
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 19, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 19, 2019 CRFA
REFUSAL PROCESSED BY MPU
Aug 19, 2019 RFRR
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 19, 2019 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Aug 8, 2019 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Aug 8, 2019 REAP
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 28, 2019 RFCR
NON-FINAL ACTION WRITTEN
Jul 27, 2019 CNRT
APPLICATION FILING RECEIPT MAILED
Jul 23, 2019 MAFR
ASSIGNED TO EXAMINER
Jul 18, 2019 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 18, 2019 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Jul 8, 2019 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jun 27, 2019 REPR